BIOMAT Database Logo BIOMAT Database Logo

[The effect of tocopherol and nicotinic acid on the microcirculation and blood coagulability in patients with ischemic heart disease]. 1990

N N Chernomorets, and G V Kotlubeĭ, and N T Vatutin, and I A Zhivotovskaia, and V B Gnilitskaia, and R E Alifanova, and E Ia Lobach, and N V Mal'tseva, and A N Mitrofanov

Patients with ischemic heart disease were treated by routine techniques (53), using also tocopherol acetate (54) and combination of tocopherol with nicotinic acid (53). Changes of the microcirculatory bed of the bulbar conjunctiva was studied biomicroscopically and in the process of blood coagulation hemoelectrocoagulographically. Complex treatment using tocopherol acetate produced a positive effect on the coagulation properties of the blood and did essentially influence the fibrinolytic activity and microcirculation. Tocopherol plus nicotinic acid resulted in normalization of the blood coagulation process, favoured activation of fibrinolysis and improvement of the microcirculatory bed.

UI MeSH Term Description Entries
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009525 Niacin A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties. Nicotinic Acid,3-Pyridinecarboxylic Acid,Enduracin,Induracin,Lithium Nicotinate,Niacin Aluminum Salt,Niacin Ammonium Salt,Niacin Calcium Salt,Niacin Cobalt (2+) Salt,Niacin Copper (2+) Salt,Niacin Hydrochloride,Niacin Iron (2+) Salt,Niacin Lithium Salt,Niacin Lithium Salt, Hemihydrate,Niacin Magnesium Salt,Niacin Manganese (2+) Salt,Niacin Potassium Salt,Niacin Sodium Salt,Niacin Tartrate,Niacin Tosylate,Niacin Zinc Salt,Nicamin,Nico-400,Nicobid,Nicocap,Nicolar,Nicotinate,Wampocap,3 Pyridinecarboxylic Acid,Aluminum Salt, Niacin,Hydrochloride, Niacin,Nico 400,Nico400,Nicotinate, Lithium,Potassium Salt, Niacin,Sodium Salt, Niacin,Tartrate, Niacin,Tosylate, Niacin
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D003228 Conjunctiva The mucous membrane that covers the posterior surface of the eyelids and the anterior pericorneal surface of the eyeball. Bulbar Conjunctiva,Palpebral Conjunctiva,Plica Semilunaris of Conjunctiva,Plicae Semilunares of Conjunctiva,Tunica Conjunctiva,Conjunctiva, Bulbar,Conjunctiva, Palpebral,Conjunctivas
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N N Chernomorets, and G V Kotlubeĭ, and N T Vatutin, and I A Zhivotovskaia, and V B Gnilitskaia, and R E Alifanova, and E Ia Lobach, and N V Mal'tseva, and A N Mitrofanov
[Effect of antibradykinin preparations and nicotinic acid on the microcirculation and blood oxygen balance of ischemic heart disease patients in the initial stage of heart failure].
August 1983, Kardiologiia,
N N Chernomorets, and G V Kotlubeĭ, and N T Vatutin, and I A Zhivotovskaia, and V B Gnilitskaia, and R E Alifanova, and E Ia Lobach, and N V Mal'tseva, and A N Mitrofanov
[Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease].
March 1988, Vrachebnoe delo,
N N Chernomorets, and G V Kotlubeĭ, and N T Vatutin, and I A Zhivotovskaia, and V B Gnilitskaia, and R E Alifanova, and E Ia Lobach, and N V Mal'tseva, and A N Mitrofanov
[Blood coagulability in ischemic heart disease and anticoagulant therapy].
October 1967, Terapevticheskii arkhiv,
N N Chernomorets, and G V Kotlubeĭ, and N T Vatutin, and I A Zhivotovskaia, and V B Gnilitskaia, and R E Alifanova, and E Ia Lobach, and N V Mal'tseva, and A N Mitrofanov
[The effect of finoptin on platelet aggregation, blood coagulability and fibrinolysis in patients with ischemic heart disease during physical exercise].
September 1991, Kardiologiia,
N N Chernomorets, and G V Kotlubeĭ, and N T Vatutin, and I A Zhivotovskaia, and V B Gnilitskaia, and R E Alifanova, and E Ia Lobach, and N V Mal'tseva, and A N Mitrofanov
[Effect of sodium nitrite on blood rheology, microcirculation and blood coagulability in patients with circulatory failure].
January 1984, Terapevticheskii arkhiv,
N N Chernomorets, and G V Kotlubeĭ, and N T Vatutin, and I A Zhivotovskaia, and V B Gnilitskaia, and R E Alifanova, and E Ia Lobach, and N V Mal'tseva, and A N Mitrofanov
[The effect of molsidomine on the conjunctival microcirculation in patients with ischemic heart disease].
November 1989, Vrachebnoe delo,
N N Chernomorets, and G V Kotlubeĭ, and N T Vatutin, and I A Zhivotovskaia, and V B Gnilitskaia, and R E Alifanova, and E Ia Lobach, and N V Mal'tseva, and A N Mitrofanov
[Influence of nicotinic acid on serum lipids in patients with ischemic heart disease].
September 1970, Vnitrni lekarstvi,
N N Chernomorets, and G V Kotlubeĭ, and N T Vatutin, and I A Zhivotovskaia, and V B Gnilitskaia, and R E Alifanova, and E Ia Lobach, and N V Mal'tseva, and A N Mitrofanov
[Effect of riboxin on hemodynamics and microcirculation in patients with chronic ischemic heart disease].
January 1983, Vrachebnoe delo,
N N Chernomorets, and G V Kotlubeĭ, and N T Vatutin, and I A Zhivotovskaia, and V B Gnilitskaia, and R E Alifanova, and E Ia Lobach, and N V Mal'tseva, and A N Mitrofanov
[Effect of biotin and pyridoxine on the provision of nicotinic acid in patients with hypertensive and ischemic heart disease].
January 1974, Voprosy pitaniia,
N N Chernomorets, and G V Kotlubeĭ, and N T Vatutin, and I A Zhivotovskaia, and V B Gnilitskaia, and R E Alifanova, and E Ia Lobach, and N V Mal'tseva, and A N Mitrofanov
Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease.
September 1980, Atherosclerosis,
Copied contents to your clipboard!